CFA
CLB icon

Camarda Financial Advisors’s Core Laboratories CLB Stock Holding History

Camarda Financial Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10
Closed -$1K – 212
2017
Q2 		$1K Buy
+10
New +$1.08K ﹤0.01% 221
2014
Q1 		– Sell
-25
Closed -$5K – 205
2013
Q4 		$5K Buy
+25
New +$4.65K ﹤0.01% 145

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Camarda Financial Advisors's CLB Position: Q3 2017 in Review

Camarda Financial Advisors sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 10 shares — an estimated $1K sold.

Camarda Financial Advisors first reported a position in CLB in Q4 2013 and held it in 2 quarters. The position peaked at $5K in Q4 2013. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Camarda Financial Advisors reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Camarda Financial Advisors sold 10 Core Laboratories shares in Q3 2017, an estimated $1K.
  • Camarda Financial Advisors first reported a position in Core Laboratories in Q4 2013 and held it in 2 quarters.
  • Camarda Financial Advisors's Core Laboratories position peaked at $5K in Q4 2013.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Camarda Financial Advisors's 13F filing for Q3 2017, filed 15 Nov 2017.